€15M, 3-year financing agreement with TECHLIFE CAPITAL and ELAIA PARTNERS
We are pleased to announce that our team will be attending the 28th ESGCT Annual Meeting to be held virtually October 19-22, 2021
Flash Therapeutics va doubler ses capacités de production de lots cliniques d’ici 2022 et amplifier la fabrication de lots à grande échelle à partir de 2023
Flash Therapeutics to double its clinical batch production capacity by 2022 and expand to large-scale batch manufacturing starting 2023
Accord de financement de 15M€ avec TECHLIFE CAPITAL et ELAIA PARTNERS sur 3 ans.
We are pleased to announce that our team will be attending the ASGCT meeting to be held virtually in May 11 - 14, 2021 in Eastern Standard Time (EST)